Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,935 GBX | +0.16% | -4.54% | +8.22% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.22% | 5.45B | |
+37.41% | 723B | |
+31.08% | 598B | |
-2.72% | 364B | |
+20.53% | 331B | |
+4.27% | 288B | |
+16.09% | 244B | |
+9.73% | 210B | |
-5.19% | 208B | |
+8.87% | 169B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Transcript : Hikma Pharmaceuticals PLC Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 09